
### [MONDO:0018470](http://purl.obolibrary.org/obo/MONDO_0018470)
**Label:** renal agenesis (disease)

**Subclasses:** [MONDO:0019636](http://purl.obolibrary.org/obo/MONDO_0019636) (renal agenesis, unilateral), [MONDO:0014319](http://purl.obolibrary.org/obo/MONDO_0014319) (renal Hypodysplasia/aplasia 2), [MONDO:0015986](http://purl.obolibrary.org/obo/MONDO_0015986) (renal agenesis, bilateral), 

**Mapped go classes:** [GO:0090722](http://purl.obolibrary.org/obo/GO_0090722) (receptor-receptor interaction), [GO:0008083](http://purl.obolibrary.org/obo/GO_0008083) (growth factor activity), [GO:0060113](http://purl.obolibrary.org/obo/GO_0060113) (inner ear receptor cell differentiation), [GO:0008284](http://purl.obolibrary.org/obo/GO_0008284) (positive regulation of cell proliferation), [GO:0060043](http://purl.obolibrary.org/obo/GO_0060043) (regulation of cardiac muscle cell proliferation), [GO:0008543](http://purl.obolibrary.org/obo/GO_0008543) (fibroblast growth factor receptor signaling pathway), [GO:0045664](http://purl.obolibrary.org/obo/GO_0045664) (regulation of neuron differentiation), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0060249](http://purl.obolibrary.org/obo/GO_0060249) (anatomical structure homeostasis), [GO:0043524](http://purl.obolibrary.org/obo/GO_0043524) (negative regulation of neuron apoptotic process), [GO:0048703](http://purl.obolibrary.org/obo/GO_0048703) (embryonic viscerocranium morphogenesis), [GO:0005104](http://purl.obolibrary.org/obo/GO_0005104) (fibroblast growth factor receptor binding), [GO:0046850](http://purl.obolibrary.org/obo/GO_0046850) (regulation of bone remodeling), [GO:0070374](http://purl.obolibrary.org/obo/GO_0070374) (positive regulation of ERK1 and ERK2 cascade), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), [GO:0031101](http://purl.obolibrary.org/obo/GO_0031101) (fin regeneration), 

**Class expressions from DL-Learner:**

- [GO:0090722](http://purl.obolibrary.org/obo/GO_0090722) (receptor-receptor interaction) 62.50%
- [GO:0048703](http://purl.obolibrary.org/obo/GO_0048703) (embryonic viscerocranium morphogenesis) 62.50%
- [GO:0031101](http://purl.obolibrary.org/obo/GO_0031101) (fin regeneration) 62.50%
- [GO:0008083](http://purl.obolibrary.org/obo/GO_0008083) (growth factor activity) 62.50%
- Thing 51.28%
- [GO:0042246](http://purl.obolibrary.org/obo/GO_0042246) (tissue regeneration) 41.37%
- [GO:0005102](http://purl.obolibrary.org/obo/GO_0005102) (receptor binding) 31.97%
- [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding) 28.92%
- [GO:0005488](http://purl.obolibrary.org/obo/GO_0005488) (binding) 28.04%
- [GO:0048018](http://purl.obolibrary.org/obo/GO_0048018) (receptor ligand activity) 27.58%
- [GO:0032502](http://purl.obolibrary.org/obo/GO_0032502) (developmental process) 27.53%
- [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) 26.75%
- [GO:0030545](http://purl.obolibrary.org/obo/GO_0030545) (receptor regulator activity) 26.37%
- [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) 26.15%
- [GO:0048589](http://purl.obolibrary.org/obo/GO_0048589) (developmental growth) 23.16%


